Manufacture

We speak with G-CON’s Maik Jornitz about his career and desire to give back by training the next generation.

Watch our video interview with Maik Jornitz.

Mighty mRNA molecules have won the COVID-19 vaccine race, but there is room for improvement.

To speed up vaccine development, we need to assess our bioconjugation approaches.

How do we vaccinate billions of people? “Nobody wins the race until everyone wins.”

Billions of vaccine doses equate to a need for billions of primary packaging units – and glass vials are still top dog.

Experts from Colorcon explain how the company’s investments in facilities and new technologies are helping the pharma sector reach its goals.

We get the rundown on mRNA vaccine manufacturing. How were the vaccines developed so quickly?

Kevin Ott from the BPSA says we should not forget how single-use plastics are saving lives.

How has COVID-19 consumer stockpiling affected the supply chains for pharma ingredients?